Transaction · 0001997710-26-000004

Hopkins Janet Jill

Hopkins Janet Jill, CMO, reported a transaction classified as grant at Aura Biosciences, Inc. involving 58850.000000 shares for an estimated $0.00. Reported holdings after the transaction were 380190.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
AURAAura Biosciences, Inc.
Trade date
Sep 01, 2026
Filing date
Sep 01, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded58.8k$0.00 per share
Holdings after380kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

AURA price since this filing

Daily closing prices, with the filing date and available return windows
AURA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001997710-26-000004
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 01, 2026, 09:24 PM · 0d delay
Shares
58,850 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
380,190 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer…

  2. F2

    The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1…

Original filing · 0001997710-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AURA